What is Benchling?

What is Benchling?

Benchling is a cloud R&D platform for biotech and pharma teams to capture experiments, structure scientific data, manage lab workflows, and run AI in scientific context. Public materials say more than 200,000 scientists and over half of the top 50 biopharma use Benchling.

Benchling started as an electronic lab notebook and has expanded into a biology-first R&D cloud covering ELN, LIMS, registry, inventory, requests, insights, and AI capabilities. Its buyers are biotech startups, large pharma, agricultural biology, and life-science platform teams that need structured experiment and sample data.

Sacra estimated Benchling at about $210M ARR in May 2024, and the company has continued positioning itself as the AI platform for R&D. The company’s last primary valuation was $6.1B in its 2021 Series F, though secondary-market estimates in 2024 were lower as SaaS and biotech multiples compressed.

Sources:Benchling homepageSacra Benchling revenue

What does Benchling offer?

Benchling offers ELN, LIMS, registry, inventory, workflow, analytics, AI, and domain-specific R&D applications.

Sources:Benchling homepageBenchling pricing

How does Benchling make money?

Benchling makes money from customized enterprise SaaS licenses, add-on capabilities, implementation services, support, and expansion across R&D organizations.

Benchling does not publish fixed per-seat pricing. Its pricing page says it customizes licensing options by product suite, add-on capabilities, solution accelerators, data platform needs, validation support, and services.

Growth is driven by landing new R&D organizations, expanding from ELN to LIMS and data foundation use cases, AI adoption, and global pharma standardization. Unit economics depend on enterprise contract size, implementation complexity, customer retention, and expansion across scientific workflows.

Sources:Benchling pricingBenchling homepage

Who leads Benchling?

Benchling is led by co-founder and CEO Sajith Wickramasekara, co-founder Ashu Singhal, finance leader Ron Gill, and functional executives across people, legal, customer experience, and marketing.

Sources:Benchling leadershipBenchling careers footer

How do you contact Benchling's leadership?

Benchling publishes contact, support, demo, and accommodations paths; verified personal executive emails are not public.

• Benchling salesSales / democontact form via benchling.com
• Benchling supportSupportsupport via benchling.com
• Sajith WickramasekaraCEO and co-foundercontact form via benchling.com
• Ron GillFinance leadercontact form via benchling.com

Sources:Benchling careers/contact footerBenchling contact

How much funding has Benchling raised?

Benchling has raised about $412M, with its last disclosed primary round a $100M Series F in November 2021 at a $6.1B valuation.

Benchling raised through seed, Series A, B, C, D, E, and F rounds as the life-science cloud category matured. Key investors across rounds include Benchmark, Thrive, Lux, ICONIQ, Altimeter, Tiger Global, Lone Pine, Franklin Templeton, and others.

The latest major disclosed financing was a November 2021 $100M Series F co-led by Altimeter and Franklin Templeton at a $6.1B valuation. Later analyses put secondary-market marks lower in 2024, but no newer primary round was verified, so the authoritative latest primary valuation remains $6.1B.

Sources:Benchling Series FSacra Benchling funding

How did Benchling get here?

Benchling evolved from ELN into a full R&D cloud for modern life sciences.

Sources:Benchling Series FBenchling EMEA GM

Who are Benchling's competitors?

Benchling competes with life-science informatics, ELN, LIMS, and scientific data platforms.

Sources:Benchling homepageTracxn Benchling competitors